Fetal EdemaSymptoms, Doctors, Treatments, Advances & More
Fetal Edema Overview
Learn About Fetal Edema
Center For Complex Obstetric Medicine
Dr. Teresa N. Sparks is an obstetrician who specializes in maternal-fetal medicine, managing the health concerns of both mother and fetus through all stages of pregnancy. She cares for women with high-risk pregnancies and those who are considering a high-risk pregnancy. She also specializes in clinical genetics, addressing genetic conditions that affect a woman or baby during pregnancy. Sparks' research investigates the causes of nonimmune hydrops fetalis, a complication of pregnancy that occurs when excessive fluid accumulates in the fetus. Her work focuses on identifying the condition's genetic causes, with the goal of developing more targeted approaches to care both before and after birth. Sparks earned her medical degree at UCSF. She completed a residency through the obstetrics and gynecology program of Brigham and Women's Hospital and Massachusetts General Hospital. She then completed a combined fellowship in maternal-fetal medicine and clinical genetics at UCSF. Sparks is a member of the American College of Obstetricians and Gynecologists, Society for Maternal-Fetal Medicine, American College of Medical Genetics and Genomics, and American Medical Association. Dr. Sparks is rated as an Elite provider by MediFind in the treatment of Fetal Edema. She is also highly rated in 12 other conditions, according to our data. Her clinical expertise encompasses Fetal Edema, Hydrops Fetalis, Hemolytic Disease of the Newborn, and Alpha Thalassemia. Dr. Sparks is board certified in American Board Of OB/Gyn/Maternal & Fetal Medicine, Maternal-Fetal Medicine, American Board Of Medical Genetics And Genomics, Clinical Genetics And Genomics, and American Board Of Obstetrics And Gynecology, Obstetrics & Gynecology. Dr. Sparks is currently accepting new patients.
Rare Disease Institute
Seth Berger, MD, PhD, returned to Children’s National Hospital as faculty in 2018. He completed the medical scientist training program at Mount Sinai School of Medicine in New York where he was awarded his MD and PhD degrees. His research at that time focused on computational analysis of signaling networks applied to prediction of adverse drug events and cardiac arrhythmia syndromes. He subsequently completed the combined pediatrics and medical genetics residency program through Children's National and the National Human Genome Research Institute at the National Institutes of Health (NIH). He spent an additional year completing the medical biochemical genetics fellowship program at NIH before returning to Children's National where he was jointly hired by the Rare Disease Institute and the Center for Genetic Medicine Research. He is interested in developing novel bioinformatics approaches applied to variant discovery for rare diseases. Dr. Berger is rated as an Elite provider by MediFind in the treatment of Fetal Edema. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Fetal Edema, Hydrops Fetalis, Hemolytic Disease of the Newborn, and Alpha Thalassemia. Dr. Berger is board certified in Medical Biochemical Genetics: American Board Of Medical Genetics And Genomics, 2019, Clinical Genetics (MD): American Board Of Medical Genetics And Genomics, 2017, and Pediatrics: American Board Of Pediatrics, 2016.
Immacolata Andolfo practices practicing medicine in Naples, Italy. Ms. Andolfo is rated as an Elite expert by MediFind in the treatment of Fetal Edema. She is also highly rated in 26 other conditions, according to our data. Her clinical expertise encompasses Anemia, Dehydrated Hereditary Stomatocytosis, Hemolytic Anemia, Hydrops Fetalis, and Splenectomy.
Summary: Each year world-wide, 2.5 million fetuses die unexpectedly in the last half of pregnancy, 25,000 in the United States, making fetal demise ten-times more common than Sudden Infant Death Syndrome. This study will apply a novel type of non-invasive monitoring, called fetal magnetocardiography (fMCG) used thus far to successfully evaluate fetal arrhythmias, in order to discover potential hidden elect...
Summary: Brief Summary: Nonimmune hydrops fetalis (NIHF) is a potentially fatal condition characterized by abnormal fluid accumulation in two or more fetal compartments. Numerous etiologies may lead to NIHF, and the underlying cause often remains unclear (1). The current standard of genetic diagnostic testing includes a fetal karyotype and chromosomal microarray (CMA), with an option to pursue single gene ...

